Campbell Lutyens and J.P. Morgan announce strategic collaboration in the secondary advisory market
LONDON & NEW YORK -- Businesswire -- Campbell Lutyens and J.P. Morgan are pleased to announce the establishment of a strategic collaboration to jointly offer their advisory services on single-asset and concentrated multi-asset continuation fund secondary transactions. The offering will enable clients to benefit from Campbell Lutyens’ and J.P. Morgan’s global, market leading secondary and Investment banking advisory practices, respectively.
The proposition combines J.P. Morgan’s global top-tier investment banking services with Campbell Lutyens’ leading global placement and secondary advisory platform, creating a best-in-class global offering for single-asset and concentrated multi-asset continuation funds. It will be available for clients across all regions and sectors in which Campbell Lutyens and J.P. Morgan both operate. The offering provides access to Campbell Lutyens’ secondaries expertise focused on fund structuring and capital raising from secondaries and institutional investors along with J.P. Morgan’s M&A services, industry expertise and capital raising capabilities.
“We are delighted to be working with J.P. Morgan and believe that our combined capabilities and experience offer a compelling proposition in the secondary advisor market,” said Immanuel Rubin, head of European and Asia Pacific secondary advisory and Gerald Cooper, head of North American secondary advisory at Campbell Lutyens. “Our clients will now have the option to benefit from the resources and expertise of both of our franchises when seeking to complete these types of complex secondary transactions.”
“The secondaries market is a fast growing and important market for our private equity and infrastructure clients globally,” said Anu Aiyengar, Global Head of Mergers & Acquisitions at J.P. Morgan. “Through our unique collaboration and complementary skillsets, we will be able to provide our clients with a comprehensive and differentiated service offering for their continuation fund projects.”
Campbell Lutyens has advised on more than US$125 billion of secondary transaction volume, completing over 290 successful secondary portfolio sales and advisory mandates. Its secondary advisory practice includes more than 50 professionals across North America, Europe and Asia Pacific.
About Campbell Lutyens
Campbell Lutyens is a global and independent private markets advisor, providing fund placement, secondary advisory and GP capital advisory services to leading fund managers and investors. With specialist knowledge in private equity, infrastructure, private credit and sustainable investing, the firm has a team of 220 operating from offices in London, Paris, New York, Los Angeles, Chicago, Charlotte, Hong Kong and Singapore.
www.campbell-lutyens.com
About J.P. Morgan
J.P. Morgan’s Corporate & Investment Bank is a global leader across banking, markets and securities services. The world’s most important corporations, governments and institutions entrust us with their business in more than 100 countries. With $28.6 trillion of assets under custody and $649.7 billion in deposits, the Corporate & Investment Bank provides strategic advice, raises capital, manages risk and extends liquidity in markets around the world. Further information about J.P. Morgan is available at www.jpmorgan.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230321005614/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:JPMorgan Chase & Co.
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 원파디, 롯데백화점 잠실점에서 팝업스토어 오픈 - 뉴스와이어
- 기아 PV5 패신저, 2026 오토카 어워즈 ‘최고의 대형차’ 선정 - 뉴스와이어
- 세리안 ‘PPZ Formula™’ 통했다… 바이오 스킨케어 초기 반응 ‘청신호’ - 뉴스와이어
- 조현준 효성그룹 회장, 전력기기 성공 신화… AI 데이터센터로 잇는다 - 뉴스와이어
- LG생활건강 이자녹스, 30년 효능 연구 ‘비타민C 42% 멜라오프 밤’ 출시 - 뉴스와이어
- 동원F&B, 복날 겨냥 이색 보양식 2종 출시 - 뉴스와이어
- 진공펌프 선정을 AI가 대신한다… 공정 조건만 입력하면 최적 펌프 자동 추천 - 뉴스와이어
- GC녹십자-앱클론, 혁신 항암제 ‘인비보 카티’ 공동 개발 - 뉴스와이어
- 환인제약 ‘ISO 27001’ 추가 획득… 품질·윤리·보안 3대 국제표준 완성 - 뉴스와이어
- 바이오사이토젠, AAALAC 정식 인증 획득으로 중개연구 및 신약 발굴 분야의 우수성 강화 - 뉴스와